188 related articles for article (PubMed ID: 10362113)
1. Breast cancer risk in ataxia telangiectasia (AT) heterozygotes: haplotype study in French AT families.
Janin N; Andrieu N; Ossian K; Laugé A; Croquette MF; Griscelli C; Debré M; Bressac-de-Paillerets B; Aurias A; Stoppa-Lyonnet D
Br J Cancer; 1999 Jun; 80(7):1042-5. PubMed ID: 10362113
[TBL] [Abstract][Full Text] [Related]
2. Incidence of cancer in 161 families affected by ataxia-telangiectasia.
Swift M; Morrell D; Massey RB; Chase CL
N Engl J Med; 1991 Dec; 325(26):1831-6. PubMed ID: 1961222
[TBL] [Abstract][Full Text] [Related]
3. Cancer risk in heterozygotes for ataxia-telangiectasia.
Geoffroy-Perez B; Janin N; Ossian K; Laugé A; Croquette MF; Griscelli C; Debré M; Bressac-de-Paillerets B; Aurias A; Stoppa-Lyonnet D; Andrieu N
Int J Cancer; 2001 Jul; 93(2):288-93. PubMed ID: 11410879
[TBL] [Abstract][Full Text] [Related]
4. Breast and other cancers in families with ataxia-telangiectasia.
Swift M; Reitnauer PJ; Morrell D; Chase CL
N Engl J Med; 1987 May; 316(21):1289-94. PubMed ID: 3574400
[TBL] [Abstract][Full Text] [Related]
5. Cancer risk according to type and location of ATM mutation in ataxia-telangiectasia families.
Cavaciuti E; Laugé A; Janin N; Ossian K; Hall J; Stoppa-Lyonnet D; Andrieu N
Genes Chromosomes Cancer; 2005 Jan; 42(1):1-9. PubMed ID: 15390180
[TBL] [Abstract][Full Text] [Related]
6. ATM haplotypes and cellular response to DNA damage: association with breast cancer risk and clinical radiosensitivity.
Angèle S; Romestaing P; Moullan N; Vuillaume M; Chapot B; Friesen M; Jongmans W; Cox DG; Pisani P; Gérard JP; Hall J
Cancer Res; 2003 Dec; 63(24):8717-25. PubMed ID: 14695186
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer incidence and the effect of cigarette smoking in heterozygous carriers of mutations in the ataxia-telangiectasia gene.
Swift M; Lukin JL
Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3188-92. PubMed ID: 18990761
[TBL] [Abstract][Full Text] [Related]
9. Ataxia-telangiectasia genes and breast cancer risk in a French family study.
Andrieu N; Cavaciuti E; Laugé A; Ossian K; Janin N; Hall J; Stoppa-Lyonnet D
J Dairy Res; 2005; 72 Spec No():73-80. PubMed ID: 16180724
[TBL] [Abstract][Full Text] [Related]
10. The role of ataxia-telangiectasia heterozygotes in familial breast cancer.
Chen J; Birkholtz GG; Lindblom P; Rubio C; Lindblom A
Cancer Res; 1998 Apr; 58(7):1376-9. PubMed ID: 9537233
[TBL] [Abstract][Full Text] [Related]
11. Cancer in homozygotes and heterozygotes of ataxia-telangiectasia and xeroderma pigmentosum in Britain.
Pippard EC; Hall AJ; Barker DJ; Bridges BA
Cancer Res; 1988 May; 48(10):2929-32. PubMed ID: 3359449
[TBL] [Abstract][Full Text] [Related]
12. Cancer risk of heterozygotes with the NBN founder mutation.
Seemanová E; Jarolim P; Seeman P; Varon R; Digweed M; Swift M; Sperling K
J Natl Cancer Inst; 2007 Dec; 99(24):1875-80. PubMed ID: 18073374
[TBL] [Abstract][Full Text] [Related]
13. [Ataxia telangiectasia: what impact in clinical oncology?].
Stoppa-Lyonnet D; Aurias A
Bull Cancer; 1992; 79(7):645-50. PubMed ID: 1467590
[TBL] [Abstract][Full Text] [Related]
14. Variation in breast cancer risk of heterozygotes for ataxia-telangiectasia according to environmental factors.
Geoffroy-Perez B; Janin N; Ossian K; Laugé A; Stoppa-Lyonnet D; Andrieu N
Int J Cancer; 2002 Jun; 99(4):619-23. PubMed ID: 11992555
[TBL] [Abstract][Full Text] [Related]
15. Risk of breast cancer in families of multiple affected women and men.
Bevier M; Sundquist K; Hemminki K
Breast Cancer Res Treat; 2012 Apr; 132(2):723-8. PubMed ID: 22179927
[TBL] [Abstract][Full Text] [Related]
16. Contribution of BRCA1 and BRCA2 germ-line mutations to the incidence of breast cancer in young women: results from a prospective population-based study in France.
Bonadona V; Sinilnikova OM; Chopin S; Antoniou AC; Mignotte H; Mathevet P; Brémond A; Martin A; Bobin JY; Romestaing P; Raudrant D; Rudigoz RC; Léoné M; Chauvin F; Easton DF; Lenoir GM; Lasset C
Genes Chromosomes Cancer; 2005 Aug; 43(4):404-13. PubMed ID: 15887246
[TBL] [Abstract][Full Text] [Related]
17. Is family history of breast cancer a marker of susceptibility to exposures in the incidence of de novo adult acute leukemia?
Rauscher GH; Sandler DP; Poole C; Pankow J; Shore D; Bloomfield CD; Olshan AF
Cancer Epidemiol Biomarkers Prev; 2003 Apr; 12(4):289-94. PubMed ID: 12692102
[TBL] [Abstract][Full Text] [Related]
18. Malignant neoplasms in the families of patients with ataxia-telangiectasia.
Swift M; Sholman L; Perry M; Chase C
Cancer Res; 1976 Jan; 36(1):209-15. PubMed ID: 1248000
[TBL] [Abstract][Full Text] [Related]
19. Identification of ataxia telangiectasia heterozygotes, a cancer-prone population, using the single-cell gel electrophoresis (Comet) assay.
Djuzenova CS; Schindler D; Stopper H; Hoehn H; Flentje M; Oppitz U
Lab Invest; 1999 Jun; 79(6):699-705. PubMed ID: 10378512
[TBL] [Abstract][Full Text] [Related]
20. Genetics and epidemiology of ataxia-telangiectasia.
Swift M
Kroc Found Ser; 1985; 19():133-46. PubMed ID: 3864935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
